Cyclerion Therapeutics, Inc. - CYCN

SEC FilingsOur CYCN Tweets

About Gravity Analytica

Recent News

  • 09.24.2025 - Pioneering a New Era in Neuropsychiatric Therapies
  • 09.24.2025 - Pioneering a New Era in Neuropsychiatric Therapies
  • 09.23.2025 - Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
  • 09.23.2025 - Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
  • 09.23.2025 - Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company

Recent Filings

  • 09.23.2025 - EX-99.1 EX-99.1
  • 09.23.2025 - 8-K Current report
  • 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 06.18.2025 - 8-K Current report
  • 05.15.2025 - EFFECT Notice of Effectiveness
  • 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.13.2025 - CORRESP Correspondence
  • 05.12.2025 - UPLOAD SEC-generated letter